Fighting SARS-CoV-2 in human blood vessel organoids

SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – a team of international scientists produced groundbreaking results in blocking viral infections in human organoids by inhibiting interactions with the SARS-CoV-2 receptor ACE2. The results are published in the renowned journal Cell.